XML 44 R24.htm IDEA: XBRL DOCUMENT v3.24.1
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2023
Income Tax Disclosure [Abstract]  
Schedule of Reconciliation of Income Tax Benefit

The reconciliation of income tax benefit at the U.S. statutory rate of 21% to the Company’s tax expense is as follows:

   December 31,   December 31, 
   2023   2022 
Federal tax benefit at statutory rate  $(1,384,472)  $(635,974)
State income tax benefit, net of federal tax effect   (452,682)   (249,847)
Rate change   (5,710)   - 
R & D tax credits   (240,000)   (83,975)
Return to provision adjustments   286,015    66,214 
Permanent differences   203,909    (21,355)
Change in valuation allowance   1,535,466    924,937 
Shortfall of stock compensation expense   40,674    - 
Other adjustments   16,800    - 
Income tax expense  $-   $- 
Schedule of Components of Deferred Tax Assets

The principal components of deferred tax assets consist of the following:

   December 31,   December 31, 
   2023   2022 
Deferred tax asset:          
Net operating loss carryforwards  $1,727,566   $1,173,451 
Fixed assets   -    

7,801

 
Intangibles (includes Section 174 capitalization)   1,197,938    399,644 
R&D tax credits   423,915    215,229 
Equity based compensation   1,251    - 
Interest & other accrued expenses   72,140    45,574 
Lease asset/(liability)   6,326    - 
Total  $3,429,136   $1,841,698 

 

   December 31,   December 31, 
Deferred tax Liabilities:  2023   2022 
Change in fair market value of securities  $(19,943)  $- 
Prepaid expenses   (30,544)   - 
Fixed assets   (2,746)   - 
Total  $(53,233)  $

-

 
           
Total deferred tax asset  $3,375,903   $1,841,698 
Less: valuation allowance   (3,375,903)   (1,841,698)
Net deferred tax asset  $-   $- 
Schedule of Effective Income Tax Rate Reconciliation

A reconciliation of the U.S. federal income tax rate to the Company’s effective tax rate is as follows:

  

   December 31,   December 31, 
   2023   2022 
Federal income tax benefit at statutory rate   21.0%   21.0%
State income tax benefit, net of federal tax effect   6.9%   8.3%
Change in tax rate   0.1%   0.0%
R&D tax credits   3.6%   2.8%
Return to provision adjustments   (4.3%)   (2.2%)
Permanent differences   (3.1%)   0.7%
Change in valuation allowance   (23.2%)   (30.5%)
Shortfall of stock compensation expense   (0.6%)   - 
Other adjustments   (0.4%)   (0.1%)
Total income tax expense   0.0%   0.0%